Millennium Management’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,203
Closed -$70.5K 5821
2025
Q4
$70.5K Sell
10,203
-2,432
-19% -$16.2K ﹤0.01% 5684
2025
Q3
$81.8K Sell
12,635
-11,429
-47% -$80.5K ﹤0.01% 5750
2025
Q2
$177K Sell
24,064
-42,549
-64% -$300K ﹤0.01% 5400
2025
Q1
$578K Buy
66,613
+55,672
+509% +$564K ﹤0.01% 4720
2024
Q4
$93.8K Buy
10,941
+178
+2% +$896 ﹤0.01% 5485
2024
Q3
$52.4K Buy
+10,763
New +$50.5K ﹤0.01% 5685
2023
Q4
Sell
-33,466
Closed -$208K 6155
2023
Q3
$208K Sell
33,466
-11,364
-25% -$71.8K ﹤0.01% 5100
2023
Q2
$282K Sell
44,830
-15,423
-26% -$79.6K ﹤0.01% 4928
2023
Q1
$242K Buy
60,253
+1,051
+2% +$4.49K ﹤0.01% 5059
2022
Q4
$267K Buy
59,202
+4,780
+9% +$31.2K ﹤0.01% 5166
2022
Q3
$408K Buy
54,422
+1,874
+4% +$15.7K ﹤0.01% 5129
2022
Q2
$425K Sell
52,548
-1,253
-2% -$9.58K ﹤0.01% 5087
2022
Q1
$437K Sell
53,801
-385
-0.7% -$3.09K ﹤0.01% 5230
2021
Q4
$433K Sell
54,186
-6,225
-10% -$57.3K ﹤0.01% 5186
2021
Q3
$617K Sell
60,411
-27,899
-32% -$284K ﹤0.01% 5154
2021
Q2
$908K Buy
+88,310
New +$895K ﹤0.01% 4752
2019
Q2
Sell
-14,869
Closed -$146K 4100
2019
Q1
$146K Sell
14,869
-327
-2% -$3.26K ﹤0.01% 3797
2018
Q4
$119K Sell
15,196
-10,173
-40% -$117K ﹤0.01% 3517
2018
Q3
$443K Buy
+25,369
New +$226K ﹤0.01% 3303
2018
Q1
Sell
-14,164
Closed -$55K 3702
2017
Q4
$55K Sell
14,164
-7,853
-36% -$28K ﹤0.01% 3717
2017
Q3
$81K Buy
+22,017
New +$67.4K ﹤0.01% 3376
2016
Q4
Sell
-22,302
Closed -$37K 3387
2016
Q3
$37K Buy
+22,302
New +$41.5K ﹤0.01% 3193

Other funds holding CSBR

Millennium Management's CSBR Position: Q1 2026 in Review

Millennium Management sold out of Champions Oncology (CSBR) in Q1 2026, closing a stake of 10,203 shares — an estimated $70.5K sold.

Millennium Management first reported a position in CSBR in Q3 2016 and held it in 22 quarters. The position peaked at $908K in Q2 2021. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Millennium Management reported no remaining Champions Oncology position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 10,203 Champions Oncology shares in Q1 2026, an estimated $70.5K.
  • Millennium Management first reported a position in Champions Oncology in Q3 2016 and held it in 22 quarters.
  • Millennium Management's Champions Oncology position peaked at $908K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.